Table 2.
Mean score of personal continuity and difference in team continuity in the different study groups
| Intervention group | Mean UPC index during trial4 (95% CI) | Mean difference in team continuity between baseline and 1 yeara (95% CI) | Mean difference in team continuity between baseline and 2 yearsa (95%CI) |
|---|---|---|---|
| Usual careb | 0.74 (0.61 to 0.86) | 0.31 (–1.14 to 1.76) | –0.05 (–1.84 to 1.74) |
| Self management | 0.36 (0.25 to 0.47) (P = 0.00) | 0.02 (–0.37 to 2.20) (P = 0.500) | –0.21 (–1.66 to 1.25) (P = 0.883) |
| Regular monitoring | 0.50 (0.39 to 0.61) (P = 0.02) | 0.87 (–0.45 to 2.19) (P = 0.528) | 0.12 (–1.43 to 1.68) (P = 0.873) |
a
Estimated marginal mean controlled for age, sex, GOLD-stage, and existence comorbidity.
b
Reference group. GOLD = Global initiative for chronic Obstructive Lung Disease. UPC = Usual Provider of Continuity (range: 0–1; team continuity range: 6–30).